{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:05:18Z","timestamp":1793822718566,"version":"4.6.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS125464"],"award-info":[{"award-number":["R21NS125464"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS123080"],"award-info":[{"award-number":["R01NS123080"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS123165"],"award-info":[{"award-number":["R01NS123165"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS134887"],"award-info":[{"award-number":["R01NS134887"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"publisher","award":["85101-NCA-22"],"award-info":[{"award-number":["85101-NCA-22"]}],"id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"publisher","award":["85113-NCA-23"],"award-info":[{"award-number":["85113-NCA-23"]}],"id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"publisher","award":["85410-NCA-24"],"award-info":[{"award-number":["85410-NCA-24"]}],"id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Activating mutations in p21-activated kinase 1 (PAK1) cause intellectual disability, neurodevelopmental abnormality, macrocephaly, and white matter anomaly in children. Oligodendroglial lineage cells undergo extensive proliferation and population expansion in human and rodent brain during early postnatal development. It remains unclear if and how PAK1 regulates oligodendroglial development. Here, using a series of genetic mouse models, we show that PAK1 controls oligodendroglial progenitor cell (OPC) proliferation and regeneration during normal brain development and in brain white matter injury. Unlike differentiating oligodendrocytes, OPCs display high levels of PAK1 kinase activity which maintains them in a proliferative progenitor state through modulating PDGFRa-mediated mitogenic signaling and acts as a molecular brake limiting OPC differentiation. PAK1-deficient or kinase-inhibited OPCs reduce their proliferation capacity and population expansion in a cell-autonomous manner. Transgenic mice carrying OPC-specific PAK1 deletion or kinase inhibition are populated with fewer OPCs in the homeostatic brain. Furthermore, OPC proliferation and intra-lesional repopulation are significantly impaired in mice of OPC-specific PAK1 deletion or kinase inhibition after white matter injury. Together, our findings suggest that kinase-activating PAK1 mutations stall OPCs in a proliferative progenitor state, impacting timely oligodendroglial differentiation in the CNS of affected children and that PAK1 is a potential molecular target for replenishing OPCs in demyelinating lesions.<\/jats:p>","DOI":"10.1007\/s00018-025-05728-3","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T05:42:59Z","timestamp":1751262179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["PAK1 regulates oligodendroglial proliferation and repopulation in homeostatic and demyelinating brain"],"prefix":"10.1007","volume":"82","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bokyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meina","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey Y.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chernoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3410-8389","authenticated-orcid":false,"given":"Fuzheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"key":"5728_CR1","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/glia.24570","volume":"72","author":"L Baudouin","year":"2024","unstructured":"Baudouin L, Ades N, Kante K, Bachelin C, Hmidan H, Deboux C, Panic R, Ben Messaoud R, Velut Y, Hamada S et al (2024) Antagonistic actions of PAK1 and NF2\/Merlin drive myelin membrane expansion in oligodendrocytes. Glia 72:1518\u20131540. https:\/\/doi.org\/10.1002\/glia.24570","journal-title":"Glia"},{"key":"5728_CR2","doi-asserted-by":"publisher","first-page":"14290","DOI":"10.1073\/pnas.1819343116","volume":"116","author":"M Baydyuk","year":"2019","unstructured":"Baydyuk M, Cha DS, Hu J, Yamazaki R, Miller EM, Smith VN, Kelly KA, Huang JK (2019) Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye. Proc Natl Acad Sci U S A 116:14290\u201314299. https:\/\/doi.org\/10.1073\/pnas.1819343116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5728_CR3","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1074\/jbc.273.14.8137","volume":"273","author":"GM Bokoch","year":"1998","unstructured":"Bokoch GM, Reilly AM, Daniels RH, King CC, Olivera A, Spiegel S, Knaus UG (1998) A GTPase-independent mechanism of p21-activated kinase activation. Regulation by sphingosine and other biologically active lipids. J Biol Chem 273:8137\u20138144. https:\/\/doi.org\/10.1074\/jbc.273.14.8137","journal-title":"J Biol Chem"},{"key":"5728_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00401-013-1112-y","volume":"125","author":"A Boyd","year":"2013","unstructured":"Boyd A, Zhang H, Williams A (2013) Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol 125:841\u2013859. https:\/\/doi.org\/10.1007\/s00401-013-1112-y","journal-title":"Acta Neuropathol"},{"key":"5728_CR5","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1523\/JNEUROSCI.0229-20.2021","volume":"41","author":"TL Brown","year":"2021","unstructured":"Brown TL, Hashimoto H, Finseth LT, Wood TL, Macklin WB (2021) PAK1 positively regulates oligodendrocyte morphology and myelination. J Neurosci 41:1864\u20131877. https:\/\/doi.org\/10.1523\/JNEUROSCI.0229-20.2021","journal-title":"J Neurosci"},{"key":"5728_CR6","doi-asserted-by":"publisher","first-page":"e2332","DOI":"10.1002\/brb3.2332","volume":"11","author":"HJ Cardona","year":"2021","unstructured":"Cardona HJ, Somasundaram A, Crabtree DM, Gadd SL, Becher OJ (2021) Prenatal overexpression of platelet-derived growth factor receptor A results in central nervous system hypomyelination. Brain Behav 11:e2332. https:\/\/doi.org\/10.1002\/brb3.2332","journal-title":"Brain Behav"},{"key":"5728_CR7","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/j.bbapap.2012.10.015","volume":"1834","author":"PH Chen","year":"2013","unstructured":"Chen PH, Chen X, He X (2013) Platelet-derived growth factors and their receptors: structural and functional perspectives. Biochim Biophys Acta 1834:2176\u20132186. https:\/\/doi.org\/10.1016\/j.bbapap.2012.10.015","journal-title":"Biochim Biophys Acta"},{"key":"5728_CR8","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1038\/s41467-018-05935-6","volume":"9","author":"HY Chow","year":"2018","unstructured":"Chow HY, Dong B, Valencia CA, Zeng CT, Koch JN, Prudnikova TY, Chernoff J (2018) Group I Paks are essential for epithelial- mesenchymal transition in an Apc-driven model of colorectal cancer. Nat Commun 9:3473. https:\/\/doi.org\/10.1038\/s41467-018-05935-6","journal-title":"Nat Commun"},{"key":"5728_CR9","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1038\/sj.onc.1205302","volume":"21","author":"LC Coles","year":"2002","unstructured":"Coles LC, Shaw PE (2002) PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway. Oncogene 21:2236\u20132244. https:\/\/doi.org\/10.1038\/sj.onc.1205302","journal-title":"Oncogene"},{"key":"5728_CR10","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/glia.24324","volume":"71","author":"JJM Cooper","year":"2023","unstructured":"Cooper JJM, Polanco JJ, Saraswat D, Peirick JJ, Seidl A, Li Y, Ma D, Sim FJ (2023) Chronic demyelination of rabbit lesions is attributable to failed oligodendrocyte progenitor cell repopulation. Glia 71:1018\u20131035. https:\/\/doi.org\/10.1002\/glia.24324","journal-title":"Glia"},{"key":"5728_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ajpath.2013.04.016","volume":"183","author":"QL Cui","year":"2013","unstructured":"Cui QL, Kuhlmann T, Miron VE, Leong SY, Fang J, Gris P, Kennedy TE, Almazan G, Antel J (2013) Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis. Am J Pathol 183:516\u2013525. https:\/\/doi.org\/10.1016\/j.ajpath.2013.04.016","journal-title":"Am J Pathol"},{"key":"5728_CR12","doi-asserted-by":"publisher","first-page":"e1009902","DOI":"10.1371\/journal.ppat.1009902","volume":"17","author":"A Davidson","year":"2021","unstructured":"Davidson A, Tyler J, Hume P, Singh V, Koronakis V (2021) A kinase-independent function of PAK is crucial for pathogen-mediated actin remodelling. PLoS Pathog 17:e1009902. https:\/\/doi.org\/10.1371\/journal.ppat.1009902","journal-title":"PLoS Pathog"},{"key":"5728_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.yjmcc.2009.10.009","volume":"48","author":"EE Egom","year":"2010","unstructured":"Egom EE, Ke Y, Musa H, Mohamed TM, Wang T, Cartwright E, Solaro RJ, Lei M (2010) FTY720 prevents ischemia\/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1\/Akt signaling. J Mol Cell Cardiol 48:406\u2013414. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.10.009","journal-title":"J Mol Cell Cardiol"},{"key":"5728_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.1190927","volume":"330","author":"B Emery","year":"2010","unstructured":"Emery B (2010) Regulation of oligodendrocyte differentiation and myelination. Science 330:779\u2013782. https:\/\/doi.org\/10.1126\/science.1190927","journal-title":"Science"},{"key":"5728_CR15","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1101\/gad.1806309","volume":"23","author":"SP Fancy","year":"2009","unstructured":"Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH (2009) Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23:1571\u20131585. https:\/\/doi.org\/10.1101\/gad.1806309. gad.1806309","journal-title":"Genes Dev"},{"key":"5728_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-neuro-061010-113629","volume":"34","author":"SP Fancy","year":"2011","unstructured":"Fancy SP, Chan JR, Baranzini SE, Franklin RJ, Rowitch DH (2011) Myelin regeneration: a recapitulation of development? Annu Rev Neurosci 34:21\u201343. https:\/\/doi.org\/10.1146\/annurev-neuro-061010-113629","journal-title":"Annu Rev Neurosci"},{"key":"5728_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nn.2855nn.2855[pii]","volume":"14","author":"SP Fancy","year":"2011","unstructured":"Fancy SP, Harrington EP, Yuen TJ, Silbereis JC, Zhao C, Baranzini SE, Bruce CC, Otero JJ, Huang EJ, Nusse R et al (2011) Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14:1009\u20131016. https:\/\/doi.org\/10.1038\/nn.2855nn.2855[pii]","journal-title":"Nat Neurosci"},{"key":"5728_CR18","doi-asserted-by":"publisher","first-page":"20997","DOI":"10.1074\/jbc.271.35.20997","volume":"271","author":"ML Galisteo","year":"1996","unstructured":"Galisteo ML, Chernoff J, Su YC, Skolnik EY, Schlessinger J (1996) The adaptor protein Nck links receptor tyrosine kinases with the serine-threonine kinase Pak1. J Biol Chem 271:20997\u201321000. https:\/\/doi.org\/10.1074\/jbc.271.35.20997","journal-title":"J Biol Chem"},{"key":"5728_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neuron.2014.06.010","volume":"83","author":"V Gallo","year":"2014","unstructured":"Gallo V, Deneen B (2014) Glial development: the crossroads of regeneration and repair in the CNS. Neuron 83:283\u2013308. https:\/\/doi.org\/10.1016\/j.neuron.2014.06.010","journal-title":"Neuron"},{"key":"5728_CR20","doi-asserted-by":"publisher","unstructured":"Gruchot J, Weyers V, Gottle P, Forster M, Hartung HP, Kury P, Kremer D (2019) The molecular basis for remyelination failure in multiple sclerosis. Cells 8. https:\/\/doi.org\/10.3390\/cells8080825","DOI":"10.3390\/cells8080825"},{"key":"5728_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ajhg.2018.09.005","volume":"103","author":"FL Harms","year":"2018","unstructured":"Harms FL, Kloth K, Bley A, Denecke J, Santer R, Lessel D, Hempel M, Kutsche K (2018) Activating mutations in PAK1, encoding p21-activated kinase 1, cause a neurodevelopmental disorder. Am J Hum Genet 103:579\u2013591. https:\/\/doi.org\/10.1016\/j.ajhg.2018.09.005","journal-title":"Am J Hum Genet"},{"key":"5728_CR22","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/hmg\/ddab106","volume":"30","author":"E Hawley","year":"2021","unstructured":"Hawley E, Gehlhausen J, Karchugina S, Chow HY, Araiza-Olivera D, Radu M, Smith A, Burks C, Jiang L, Li X et al (2021) PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2). Hum Mol Genet 30:1607\u20131617. https:\/\/doi.org\/10.1093\/hmg\/ddab106","journal-title":"Hum Mol Genet"},{"key":"5728_CR23","doi-asserted-by":"publisher","first-page":"a009100","DOI":"10.1101\/cshperspect.a009100","volume":"5","author":"CH Heldin","year":"2013","unstructured":"Heldin CH, Lennartsson J (2013) Structural and functional properties of platelet-derived growth factor and stem cell factor receptors. Cold Spring Harb Perspect Biol 5:a009100. https:\/\/doi.org\/10.1101\/cshperspect.a009100","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5728_CR24","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/ncb1795","volume":"10","author":"M Higuchi","year":"2008","unstructured":"Higuchi M, Onishi K, Kikuchi C, Gotoh Y (2008) Scaffolding function of PAK in the PDK1-Akt pathway. Nat Cell Biol 10:1356\u20131364. https:\/\/doi.org\/10.1038\/ncb1795","journal-title":"Nat Cell Biol"},{"key":"5728_CR25","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/brain\/awz264","volume":"142","author":"S Horn","year":"2019","unstructured":"Horn S, Au M, Basel-Salmon L, Bayrak-Toydemir P, Chapin A, Cohen L, Elting MW, Graham JM, Gonzaga-Jauregui C, Konen O et al (2019) De novo variants in PAK1 lead to intellectual disability with macrocephaly and seizures. Brain 142:3351\u20133359. https:\/\/doi.org\/10.1093\/brain\/awz264","journal-title":"Brain"},{"issue":"594\u2013608","key":"5728_CR26","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.1016\/j.cell.2020.06.027","volume":"182","author":"W Huang","year":"2020","unstructured":"Huang W, Bhaduri A, Velmeshev D, Wang S, Wang L, Rottkamp CA, Alvarez-Buylla A, Rowitch DH, Kriegstein AR (2020) Origins and proliferative states of human oligodendrocyte precursor cells. Cell 182(594\u2013608):e511. https:\/\/doi.org\/10.1016\/j.cell.2020.06.027","journal-title":"Cell"},{"key":"5728_CR27","doi-asserted-by":"publisher","first-page":"144991","DOI":"10.1016\/j.gene.2020.144991","volume":"760","author":"R Kanumuri","year":"2020","unstructured":"Kanumuri R, Saravanan R, Pavithra V, Sundaram S, Rayala SK, Venkatraman G (2020) Current trends and opportunities in targeting p21 activated kinase-1(PAK1) for therapeutic management of breast cancers. Gene 760:144991. https:\/\/doi.org\/10.1016\/j.gene.2020.144991","journal-title":"Gene"},{"key":"5728_CR28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1021\/acsmedchemlett.5b00102","volume":"6","author":"AS Karpov","year":"2015","unstructured":"Karpov AS, Amiri P, Bellamacina C, Bellance MH, Breitenstein W, Daniel D, Denay R, Fabbro D, Fernandez C, Galuba I et al (2015) Optimization of a dibenzodiazepine hit to a potent and selective allosteric PAK1 inhibitor. ACS Med Chem Lett 6:776\u2013781. https:\/\/doi.org\/10.1021\/acsmedchemlett.5b00102","journal-title":"ACS Med Chem Lett"},{"key":"5728_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/cge.13618","volume":"96","author":"KD Kernohan","year":"2019","unstructured":"Kernohan KD, McBride A, Hartley T, Rojas SK, Care4Rare Canada C, Dyment DA, Boycott KM, Dyack S (2019) p21 protein-activated kinase 1 is associated with severe regressive autism, and epilepsy. Clin Genet 96:449\u2013455. https:\/\/doi.org\/10.1111\/cge.13618","journal-title":"Clin Genet"},{"key":"5728_CR30","doi-asserted-by":"publisher","unstructured":"Kim HJ, Miron VE, Dukala D, Proia RL, Ludwin SK, Traka M, Antel JP, Soliven B (2011) Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model. FASEB J fj.10\u2013173203. https:\/\/doi.org\/10.1096\/fj.10-173203","DOI":"10.1096\/fj.10-173203"},{"key":"5728_CR31","doi-asserted-by":"publisher","first-page":"65064","DOI":"10.18632\/oncotarget.17775","volume":"8","author":"JY Kim","year":"2017","unstructured":"Kim JY, Jeong HS, Chung T, Kim M, Lee JH, Jung WH, Koo JS (2017) The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: A comparative study with Ki67. Oncotarget 8:65064\u201365076. https:\/\/doi.org\/10.18632\/oncotarget.17775","journal-title":"Oncotarget"},{"key":"5728_CR32","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1523\/JNEUROSCI.3467-12.2013","volume":"33","author":"J Lang","year":"2013","unstructured":"Lang J, Maeda Y, Bannerman P, Xu J, Horiuchi M, Pleasure D, Guo F (2013) Adenomatous polyposis coli regulates oligodendroglial development. J Neurosci 33:3113\u20133130. https:\/\/doi.org\/10.1523\/JNEUROSCI.3467-12.2013","journal-title":"J Neurosci"},{"key":"5728_CR33","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.111.048785","volume":"124","author":"W Liu","year":"2011","unstructured":"Liu W, Zi M, Naumann R, Ulm S, Jin J, Taglieri DM, Prehar S, Gui J, Tsui H, Xiao RP et al (2011) Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart. Circulation 124:2702\u20132715. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.048785","journal-title":"Circulation"},{"key":"5728_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.nbd.2016.12.004","volume":"98","author":"MRL Maglorius Renkilaraj","year":"2017","unstructured":"Maglorius Renkilaraj MRL, Baudouin L, Wells CM, Doulazmi M, Wehrle R, Cannaya V, Bachelin C, Barnier JV, Jia Z, Nait Oumesmar B et al (2017) The intellectual disability protein PAK3 regulates oligodendrocyte precursor cell differentiation. Neurobiol Dis 98:137\u2013148. https:\/\/doi.org\/10.1016\/j.nbd.2016.12.004","journal-title":"Neurobiol Dis"},{"key":"5728_CR35","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/S0002-9440(10)63726-1","volume":"164","author":"JL Mason","year":"2004","unstructured":"Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, Goldman JE, Matsushima GK (2004) Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol 164:1673\u20131682. https:\/\/doi.org\/10.1016\/S0002-9440(10)63726-1. (S0002-9440(10)63726-1)","journal-title":"Am J Pathol"},{"key":"5728_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12035-008-8032-1","volume":"37","author":"M Nikolic","year":"2008","unstructured":"Nikolic M (2008) The Pak1 kinase: an important regulator of neuronal morphology and function in the developing forebrain. Mol Neurobiol 37:187\u2013202. https:\/\/doi.org\/10.1007\/s12035-008-8032-1","journal-title":"Mol Neurobiol"},{"key":"5728_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.semcdb.2021.02.004","volume":"116","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama A, Shimizu T, Sherafat A, Richardson WD (2021) Life-long oligodendrocyte development and plasticity. Semin Cell Dev Biol 116:25\u201337. https:\/\/doi.org\/10.1016\/j.semcdb.2021.02.004","journal-title":"Semin Cell Dev Biol"},{"key":"5728_CR38","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.1073\/pnas.1103350108","volume":"108","author":"CC Ong","year":"2011","unstructured":"Ong CC, Jubb AM, Haverty PM, Zhou W, Tran V, Truong T, Turley H, O\u2019Brien T, Vucic D, Harris AL et al (2011) Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells. Proc Natl Acad Sci U S A 108:7177\u20137182. https:\/\/doi.org\/10.1073\/pnas.1103350108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5728_CR39","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/brain\/awl217","volume":"129","author":"P Patrikios","year":"2006","unstructured":"Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Bruck W, Lucchinetti C, Lassmann H (2006) Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129:3165\u20133172. https:\/\/doi.org\/10.1093\/brain\/awl217","journal-title":"Brain"},{"key":"5728_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s0014-5793(01)02965-9","volume":"507","author":"J Roig","year":"2001","unstructured":"Roig J, Tuazon PT, Traugh JA (2001) Cdc42-independent activation and translocation of the cytostatic p21-activated protein kinase gamma-PAK by sphingosine. FEBS Lett 507:195\u2013199. https:\/\/doi.org\/10.1016\/s0014-5793(01)02965-9","journal-title":"FEBS Lett"},{"key":"5728_CR41","doi-asserted-by":"publisher","first-page":"39291","DOI":"10.1074\/jbc.M112.404061","volume":"287","author":"B Sanchez-Solana","year":"2012","unstructured":"Sanchez-Solana B, Motwani M, Li DQ, Eswaran J, Kumar R (2012) p21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor. J Biol Chem 287:39291\u201339302. https:\/\/doi.org\/10.1074\/jbc.M112.404061","journal-title":"J Biol Chem"},{"key":"5728_CR42","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1212\/01.wnl.0000343049.00540.c8","volume":"72","author":"R Schiffmann","year":"2009","unstructured":"Schiffmann R, van der Knaap MS (2009) Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 72:750\u2013759. https:\/\/doi.org\/10.1212\/01.wnl.0000343049.00540.c8","journal-title":"Neurology"},{"key":"5728_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pediatrneurol.2023.09.005","volume":"149","author":"G Scorrano","year":"2023","unstructured":"Scorrano G, D\u2019Onofrio G, Accogli A, Severino M, Buchert R, Kotzaeridou U, Iapadre G, Farello G, Iacomino M, Dono F et al (2023) A PAK1 mutational hotspot within the regulatory CRIPaK domain is associated with severe neurodevelopmental disorders in children. Pediatr Neurol 149:84\u201392. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2023.09.005","journal-title":"Pediatr Neurol"},{"key":"5728_CR44","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1038\/onc.2011.515","volume":"31","author":"Y Shrestha","year":"2012","unstructured":"Shrestha Y, Schafer EJ, Boehm JS, Thomas SR, He F, Du J, Wang S, Barretina J, Weir BA, Zhao JJ et al (2012) PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene 31:3397\u20133408. https:\/\/doi.org\/10.1038\/onc.2011.515","journal-title":"Oncogene"},{"key":"5728_CR45","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1093\/brain\/awq257","volume":"133","author":"ME Steenweg","year":"2010","unstructured":"Steenweg ME, Vanderver A, Blaser S, Bizzi A, de Koning TJ, Mancini GM, van Wieringen WN, Barkhof F, Wolf NI, van der Knaap MS (2010) Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain 133:2971\u20132982. https:\/\/doi.org\/10.1093\/brain\/awq257","journal-title":"Brain"},{"key":"5728_CR46","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1093\/brain\/awac307","volume":"145","author":"V Tepavcevic","year":"2022","unstructured":"Tepavcevic V, Lubetzki C (2022) Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier? Brain 145:4178\u20134192. https:\/\/doi.org\/10.1093\/brain\/awac307","journal-title":"Brain"},{"key":"5728_CR47","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/brv.12815","volume":"97","author":"Y Wang","year":"2022","unstructured":"Wang Y, Guo F (2022) Group I PAKs in myelin formation and repair of the central nervous system: what, when, and how. Biol Rev Camb Philos Soc 97:615\u2013639. https:\/\/doi.org\/10.1111\/brv.12815","journal-title":"Biol Rev Camb Philos Soc"},{"key":"5728_CR48","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.celrep.2018.07.061","volume":"24","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zeng C, Li J, Zhou Z, Ju X, Xia S, Li Y, Liu A, Teng H, Zhang K et al (2018) PAK2 haploinsufficiency results in synaptic cytoskeleton impairment and autism-related behavior. Cell Rep 24:2029\u20132041. https:\/\/doi.org\/10.1016\/j.celrep.2018.07.061","journal-title":"Cell Rep"},{"key":"5728_CR49","doi-asserted-by":"publisher","first-page":"109695","DOI":"10.1016\/j.celrep.2021.109695","volume":"37","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang Y, Zhang S, Kim B, Hull VL, Xu J, Prabhu P, Gregory M, Martinez-Cerdeno V, Zhan X et al (2021) PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination. Cell Rep 37:109695. https:\/\/doi.org\/10.1016\/j.celrep.2021.109695","journal-title":"Cell Rep"},{"key":"5728_CR50","doi-asserted-by":"publisher","first-page":"20093","DOI":"10.1074\/jbc.M112.426023","volume":"288","author":"Z Wang","year":"2013","unstructured":"Wang Z, Fu M, Wang L, Liu J, Li Y, Brakebusch C, Mei Q (2013) p21-activated kinase 1 (PAK1) can promote ERK activation in a kinase-independent manner. J Biol Chem 288:20093\u201320099. https:\/\/doi.org\/10.1074\/jbc.M112.426023","journal-title":"J Biol Chem"},{"key":"5728_CR51","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/brain\/awf031","volume":"125","author":"G Wolswijk","year":"2002","unstructured":"Wolswijk G (2002) Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125:338\u2013349. https:\/\/doi.org\/10.1093\/brain\/awf031","journal-title":"Brain"},{"key":"5728_CR52","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1523\/JNEUROSCI.2386-20.2021","volume":"41","author":"S Zhang","year":"2021","unstructured":"Zhang S, Wang Y, Zhu X, Song L, Zhan X, Ma E, McDonough J, Fu H, Cambi F, Grinspan J, Guo F (2021) The Wnt effector TCF7l2 promotes oligodendroglial differentiation by repressing autocrine BMP4-mediated signaling. J Neurosci 41:1650\u20131664. https:\/\/doi.org\/10.1523\/JNEUROSCI.2386-20.2021","journal-title":"J Neurosci"},{"key":"5728_CR53","doi-asserted-by":"publisher","first-page":"9505","DOI":"10.1523\/JNEUROSCI.1510-18.2018","volume":"38","author":"K Zheng","year":"2018","unstructured":"Zheng K, Wang C, Yang J, Huang H, Zhao X, Zhang Z, Qiu M (2018) Molecular and genetic evidence for the PDGFRalpha-independent population of oligodendrocyte progenitor cells in the developing mouse brain. J Neurosci 38:9505\u20139513. https:\/\/doi.org\/10.1523\/JNEUROSCI.1510-18.2018","journal-title":"J Neurosci"},{"key":"5728_CR54","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.06.579239","author":"M Zhu","year":"2024","unstructured":"Zhu M, Wang Y, Park J, Titus A, Guo F (2024) Dispensable regulation of brain development and myelination by the immune-related molecule Serpina3n. J Neurochem. https:\/\/doi.org\/10.1101\/2024.02.06.579239","journal-title":"J Neurochem"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05728-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05728-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05728-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T06:02:54Z","timestamp":1751263374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05728-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5728"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05728-3","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"11 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal work was approved by UC Davis IACUC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors were aware of and gave permission for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no conflict of interest and all consented to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}